Annual report pursuant to Section 13 and 15(d)

Income Taxes (Tables)

v3.22.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2021
Income Tax Disclosure [Abstract]  
Schedule of provision for (benefit from) income taxes
    December 31,  
    2021     2020  
Current            
U.S. Federal   $
    $
 
State and local    
     
 
    $
    $
 
Deferred                
U.S. Federal   $

(2,360,923

)   $
 
State and local    

(561,059

)    
 
    $

(2,921,982

)   $
 
Total                
U.S. Federal   $

(2,360,923

)   $
 
State and local    

(561,059

)    
 
    $

(2,921,982

)   $
 

 

Schedule of deferred tax assets and liabilities
    December 31,  
    2021     2020  
Deferred Tax Assets:            
Tax benefit of net operating loss carry-forward   $ 17,577,952     $ 14,064,563  
Accrued liabilities     69,525       327,749  
Stock based compensation     1,630,004       1,252,855  
Deferred Rent     159,558       15,778  
R&D Credit     1,046,841       1,054,989  
Total deferred tax assets     20,483,880       16,715,934  
                 
Deferred Tax Liabilities:                
Depreciation     (12,706 )     (36,897 )
Amortization     (5,331 )     (9,670 )
Intangibles     (5,743,441 )    
-
 
Deferred Rent     (193,482 )     (14,344 )
Total deferred tax liabilities     (5,954,960 )     (60,911 )
Total net deferred tax assets     14,528,920       16,655,023  
Valuation allowance for deferred tax assets     (14,528,920 )     (16,655,023 )
Deferred tax assets, net of valuation allowance   $
-
    $
-
 

Schedule of valuation allowance
    Years Ended
December 31,
 
    2021     2020  
             
Beginning of the year   $ 16,655,023     $ 13,102,327  
Change in valuation account     (2,126,103 )     3,552,696  
End of the year   $ 14,528,920     $ 16,655,023  

 

Schedule of provision for income taxes with the amounts
    Years Ended
December 31,
 
    2021     2020  
U.S. federal statutory rate     (21.0 )%     (21.0 )%
Federal True Ups     0.5 %     1.8 %
State taxes, net of federal benefit     14.01 %     (6.2 )%
Change in valuation allowance    
(11,85
)%     26.4 %
Nondeductible Expenses     2.01 %     0.5 %
R&D Credit     0.05 %     (1.5 )%
Effective income tax rate     (16.28 )%     0.0 %